Ku et al. also indicated that a combination strategy involving CHI3L1(YKL40) inhibition by shRNA and several anticancer drugs, including cisplatin, etoposide, and doxorubicin, could enhance glioblastoma cell death [75]. This evidence concerns the gene CHI3L1 and glioblastoma.